Biogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% -...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen (BIIB +0.7%) moves up after Deutsche Bank says it conducted a survey and found that 40% - 57% of patients taking Baxter's (BAX +0.1%) Advate would consider switching to BIIB's new hemophilia treatment if the price was right.